Literature DB >> 2887929

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy.

P von Wussow, M Freund, B Block, H Diedrich, H Poliwoda, H Deicher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2887929     DOI： 10.1016/s0140-6736(87)93034-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  [2 year interferon therapy of metastatic carcinoid tumor].

Authors:  W von Scheidt; M Böhm; I Huber; R Habersetzer; K Jacob; A Markl; G Autenrieth
Journal:  Klin Wochenschr       Date:  1990-02-15

2.  Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA.

Authors:  G P Rajan; B Seifert; O Prümmer; H I Joller-Jemelka; G Burg; R Dummer
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

3.  Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.

Authors:  N S Zeidner; M H Myles; C K Mathiason-DuBard; M J Dreitz; J I Mullins; E A Hoover
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Presence of interferon and anti-interferon in patients with systemic lupus erythematosus.

Authors:  P von Wussow; D Jakschies; K Hartung; H Deicher
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  Effectiveness of leukocyte interferon-alpha treatment in patients with chronic hepatitis C not responsive to recombinant interferon.

Authors:  G Scotto; M Grimaldi
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

6.  Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis.

Authors:  Y Ikeda; G Toda; N Hashimoto; N Umeda; K Miyake; M Yamanaka; K Kurokowa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

7.  High dose interferon treatment in chronic hepatitis C.

Authors:  S Iino
Journal:  Gut       Date:  1993       Impact factor: 23.059

8.  Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue.

Authors:  E Selzer; A Wilfing; V Sexl; M Freissmuth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

9.  No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.

Authors:  C Bokemeyer; B Kynast; A Harstrick; E Laage; E Schmoll; P von Wussow; H J Schmoll
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.

Authors:  L E Rönnblom; E T Janson; A Perers; K E Oberg; G V Alm
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.